Ovarian function recovery in newly diagnosed advanced Hodgkin lymphoma patients treated with PET-adapted regimen: prospective analysis of a mu Iticentric randomized phase 3 trial (AHL2011)

被引：0
|
作者：
Demeestere, I. [1 ]
Dechene, J. [1 ]
Racape, J. [2 ,3 ]
Bouabdallah, R. [4 ]
Brice, P. [5 ]
Ghesquieres, H. [6 ]
Stamatoulas, A. [7 ]
Dupuisl, J. [8 ]
Gac, A. G. [9 ]
Gastinne, T. [10 ]
Joly', B. [11 ]
Bouabdallah, K. [12 ]
Casasnovas, O., I [13 ,14 ]
机构：
[1] Univ Libre Bruxelles, Res Lab Human Reprod, Brussels, Belgium
[2] Univ Libre Bruxelles, Res Ctr Epidemiol, Sch Publ Hlth, Brussels, Belgium
[3] CUB Erasme, Biomed Res Dept, Brussels, Belgium
[4] Inst P Caimette, Dept Hematol, Marseille, France
[5] Hop St Louis, AP HP, Dept Hematol, Paris, France
[6] Univ Claude Bernard Lyon 1, Lyon Ctr Hosp Lyon Sud, Hosp Civils Lyon, Dept Hematol, Pierre Benite, France
[7] Ctr H Becquerel, Dept Hematol, Rouen, France
[8] H Mondor Hosp, Dept Hematol, Creteil, France
[9] Inst Hematol Basse Normandie, Dept Hematol, Caen, France
[10] Univ Hosp Nantes, Dept Hematol, Nantes, France
[11] Sud Francilien Hosp, Dept Hematol, Corbeil Essonnes, France
[12] CHU Bordeaux, Dept Hematol, Bordeaux, France
[13] Univ Hosp F Mitterrand, Dijon, France
[14] INSERM, Dept Hematol, UMR 1231, Dijon, France
来源：
HUMAN REPRODUCTION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-035
引用
收藏
页码：17 / 18
页数：2
相关论文
共 10 条
  • [1] Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
    Demeestere, Isabelle
    Racape, Judith
    Dechene, Julie
    Dupuis, Jehan
    Morschhauser, Franck
    De Wilde, Virginie
    Lazarovici, Julien
    Ghesquieres, Herve
    Touati, Mohamed
    Sibon, David
    Alexis, Magda
    Gac, Anne-Claire
    Moatti, Hannah
    Virelizier, Emmanuelle
    Maisonneuve, Herve
    Pranger, Delphine
    Houot, Roch
    Fornecker, Luc-Matthieu
    Tempescul, Adrian
    Andre, Marc
    Casasnovas, Rene-Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (29) : 3251 - +
  • [2] PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
    Casasnovas, Rene-Olivier
    Bouabdallah, Reda
    Brice, Pauline
    Lazarovici, Julien
    Ghesquieres, Herve
    Stamatoullas, Aspasia
    Dupuis, Jehan
    Gac, Anne-Claire
    Gastinne, Thomas
    Joly, Bertrand
    Bouabdallah, Krimo
    Nicolas-Virelizier, Emmanuelle
    Feugier, Pierre
    Morschhauser, Franck
    Delarue, Richard
    Farhat, Hassan
    Quittet, Philippe
    Berriolo-Riedinger, Alina
    Ternpescul, Adrian
    Edeline, Veronique
    Maisonneuve, Nerve
    Fomecker, Luc-Matthieu
    Lamy, Thiery
    Delmer, Alain
    Dartigues, Peggy
    Martin, Laurent
    Andre, Marc
    Moonier, Nicolas
    Traverse-Glehen, Alexandra
    Meignan, Michel
    LANCET ONCOLOGY, 2019, 20 (02): : 202 - 215
  • [3] Influence of Sociodemographic Determinants on the Hodgkin Lymphoma Baseline Characteristics in Long Survivors Patients Enrolled in the Prospective Phase 3 Trial AHL2011
    Chevreux, Steeve
    de Barros, Sandra
    Laurent, Camille
    Durand, Amandine
    Delpierre, Cyrille
    Robert, Philippine
    Joubert, Clementine
    Griolet, Samuel
    Kanoun, Salim
    Bastie, Jean-Noel
    Casasnovas, Rene-Olivier
    Rossi, Cedric
    CANCERS, 2023, 15 (01)
  • [4] First Line Therapy Evaluation Using Propensity Score Approach in Newly Diagnosed Advanced Classical Hodgkin Lymphoma Patients from Prospective Real-World Realysa Cohort and Phase 3 AHL2011 Trial
    Rossi, Cedric
    Marouf, Amira
    Fischer, Benedicte Deau
    Cherblanc, Fanny
    Cugnod, Emeline
    Chartier, Loic
    Fornecker, Luc Matthieu
    Andre, Marc
    Casasnovas, Rene-Olivier
    Ghesquieres, Herve
    BLOOD, 2023, 142
  • [5] Randomized phase III study comparing an early PET driven treatment deescalation to a not PET-monitored strategy in patients with advanced stages Hodgkin lymphoma: Final analysis of the AHL2011 LYSA study.
    Casasnovas, Olivier
    Brice, Pauline
    Bouabdallah, Reda
    Salles, Gilles A.
    Stamatoulas, Aspasia
    Dupuis, Jehan
    Reman, Oumedaly
    Gastinne, Thomas
    Joly, Bertrand
    Bouabdallah, Kamal
    Nicolas-Virelizier, Emmanuelle
    Feugier, Pierre
    Morschhauser, Franck
    Delarue, Richard
    Berriolo-Riedinger, Alina
    Edeline, Veronique
    Traverse-Glehen, Alexandra
    Andre, Marc
    Mounier, Nicolas
    Meignan, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Randomized Phase III Study Comparing an Early PET Driven Treatment De Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study
    Casasnovas, Olivier
    Brice, Pauline
    Bouabdallah, Reda
    Salles, Gilles A.
    Stamatoullas, Aspasia
    Dupuis, Jehan
    Reman, Oumedaly
    Gastinne, Thomas
    Joly, Bertrand
    Bouabdallah, Krimo
    Nicolas-Virelizier, Emmanuelle
    Bologna, Serge
    Morschhauser, Franck
    Delarue, Richard
    Farhat, Hassan
    Quittet, Philippe
    Berriolo-Riedinger, Alina
    Tempescul, Adrian
    Edeline, Veronique
    Maisonneuve, Herve
    Eisenmann, Jean Claude
    Traverse-Glehen, Alexandra
    Andre, Marc
    Mounier, Nicolas
    Meignan, Michel
    Ferme, Christophe
    BLOOD, 2015, 126 (23)
  • [7] Randomized Phase III Study Comparing an Early PET-Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients With Advanced-Stages Hodgkin Lymphoma: Final Analysis of the AHL2011 LYSA Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 9 - 11
  • [8] Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial
    Anderson, Richard A.
    Remedios, Rachel
    Kirkwood, Amy A.
    Patrick, Pip
    Stevens, Linsey
    Clifton-Hadley, Laura
    Roberts, Tom
    Hatton, Chris
    Kalakonda, Nagesh
    Milligan, Don W.
    McKay, Pam
    Rowntree, Clare
    Scott, Fiona M.
    Johnson, Peter W. M.
    LANCET ONCOLOGY, 2018, 19 (10): : 1328 - 1337
  • [9] Feasibility of Interim PET-Adapted Therapy in HIV-Positive Patients with Advanced Hodgkin Lymphoma (HL): Sub-Analysis of SWOG S0816 Phase 2 Trial
    Danilov, Alexey V.
    Li, Hongli
    Press, Oliver W.
    Shapira, Ilan
    Swinnen, Lode J.
    Noy, Ariela
    Reid, Erin
    Smith, Sonali M.
    Friedberg, Jonathan W.
    BLOOD, 2015, 126 (23)
  • [10] Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
    Pothuri, Bhavana
    Han, Sileny
    Chase, Dana M.
    Heitz, Florian
    Burger, Robert A.
    Gaba, Lydia
    Van Le, Linda
    Guerra, Eva
    Bender, David
    Korach, Jacob
    Cloven, Noelle
    Churruca, Cristina
    Follana, Philippe
    DiSilvestro, Paul
    Baurain, Jean-Francois
    Jardon, Kris
    Pisano, Carmela
    Peen, Ulla
    Maenpaa, Johanna
    Gupta, Divya
    Bacque, Emeline
    Li, Yong
    Compton, Natalie
    Antonova, Jenya
    Monk, Bradley J.
    Gonzalez-Martin, Antonio
    GYNECOLOGIC ONCOLOGY, 2024, 184 : 168 - 177
1